Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D van der Heijde

Showing results (41-50 of 218) with videos related to

Pageof 22
Sort By:
British Journal of Rheumatology|August 1, 1997
The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrumentZ de Jong, D van der Heijde, S P McKenna, et al.
Annals of the Rheumatic Diseases|June 20, 2014
Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with psoriatic arthritis: results of a phase 3 double-blind randomised placebo-controlled studyA Kavanaugh, D Gladman, D van der Heijde, et al.
Clinical and Experimental Rheumatology|December 5, 2002
Imaging and scoring in ankylosing spondylitisJ Braun, W Golder, M Bollow, et al.
The Journal of Rheumatology|May 1, 2001
Recent rheumatoid arthritis clinical trials using radiographic endpoints--updated research agendaV Strand, M Lassere, D van der Heijde, et al.
Annals of the Rheumatic Diseases|April 15, 2004
Which patients with ankylosing spondylitis should be treated with tumour necrosis factor inhibiting therapy? A survey among Dutch rheumatologistsR Landewé, B Rump, D van der Heijde, et al.
Annals of the Rheumatic Diseases|May 14, 2004
Long term evaluation of radiographic disease progression in a subset of patients with rheumatoid arthritis treated with leflunomide beyond 2 yearsD van der Heijde, J Kalden, D Scott, et al.
Annals of the Rheumatic Diseases|March 24, 2004
Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months' follow upK Bruynesteyn, R Landewé, Sj van der Linden, et al.
Annals of the Rheumatic Diseases|October 13, 2005
Twenty-eight-joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints: a comparison with the original DAS remissionR Landewé, D van der Heijde, S van der Linden, et al.
Rheumatology (Oxford, England)|October 27, 1999
Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritisD van der Heijde, T Dankert, F Nieman, et al.
British Journal of Rheumatology|August 1, 1997
Quality of life in rheumatoid arthritisD Whalley, S P McKenna, Z de Jong, et al.
Pageof 22

Showing results (41-50 of 218) with videos related to

Sort By:
Pageof 22
British Journal of Rheumatology|August 1, 1997
The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrumentZ de Jong, D van der Heijde, S P McKenna, et al.
Annals of the Rheumatic Diseases|June 20, 2014
Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with psoriatic arthritis: results of a phase 3 double-blind randomised placebo-controlled studyA Kavanaugh, D Gladman, D van der Heijde, et al.
Clinical and Experimental Rheumatology|December 5, 2002
Imaging and scoring in ankylosing spondylitisJ Braun, W Golder, M Bollow, et al.
The Journal of Rheumatology|May 1, 2001
Recent rheumatoid arthritis clinical trials using radiographic endpoints--updated research agendaV Strand, M Lassere, D van der Heijde, et al.
Annals of the Rheumatic Diseases|April 15, 2004
Which patients with ankylosing spondylitis should be treated with tumour necrosis factor inhibiting therapy? A survey among Dutch rheumatologistsR Landewé, B Rump, D van der Heijde, et al.
Annals of the Rheumatic Diseases|May 14, 2004
Long term evaluation of radiographic disease progression in a subset of patients with rheumatoid arthritis treated with leflunomide beyond 2 yearsD van der Heijde, J Kalden, D Scott, et al.
Annals of the Rheumatic Diseases|March 24, 2004
Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months' follow upK Bruynesteyn, R Landewé, Sj van der Linden, et al.
Annals of the Rheumatic Diseases|October 13, 2005
Twenty-eight-joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints: a comparison with the original DAS remissionR Landewé, D van der Heijde, S van der Linden, et al.
Rheumatology (Oxford, England)|October 27, 1999
Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritisD van der Heijde, T Dankert, F Nieman, et al.
British Journal of Rheumatology|August 1, 1997
Quality of life in rheumatoid arthritisD Whalley, S P McKenna, Z de Jong, et al.
Pageof 22